Please ensure Javascript is enabled for purposes of website accessibility Proveedor de Biote | Terapia de Reemplazo Hormonal Bioidéntico de Biote en 550 Deep Valley Drive en Rolling Hills Estates CA 90274
BIOTE PROVIDER
Map Marker550 Deep Valley Drive STE 280, Rolling Hills Estates, CA, 90274

BIOTE PROVIDER

Global Premier Fertility-Los Angeles, PC

Rolling Hills Estates CA 90274 Hormone Replacement Therapy
Specialty: OBSTETRICS AND GYNECOLOGY
At This Location: MD
Serving: Women, Men
Nutraceuticals: Yes

Every day, millions of people experience a hormone imbalance. From fatigue and weight gain to severe mood changes and low libido, many are left with feelings of discomfort, unaware of how they may help alleviate these common issues. Your Biote Certified Provider in Rolling Hills Estates CA 90274 specializes in hormone optimization to help these and other symptoms of aging with personalized care plans and precision treatments to help you age healthier.

We have been certified to offer Biote's method of hormone therapy in our Rolling Hills Estates CA 90274 office. Biote has provided bioidentical hormone replacement therapy (BHRT) for more than a decade, helping both men and women age healthier with hormone optimization. To schedule an evaluation and learn how to restore hormones to their optimal level to help address specific health concerns, contact us today.

Matthew Macer, MD

Dr. Matthew Macer is a specialist in Reproductive Endocrinology and Infertility. He completed his Medical Degree at the University of Southern California, then specialization in Obstetrics and Gynecology at Yale University where he became certified in Robotic Surgery and was awarded the “Best Resident Surgeon” award by the American Academy of Gynecologic Laparoscopy. Following his residency, Dr. Macer was selected out of 200 candidates to complete his sub-specialization in Reproductive Endocrinology and Infertility at the University of California – Los Angeles. He now practices in Southern California and is an expert in infertility, fertility preservation, hormone therapy, endometriosis and minimally invasive surgery.